TR-1: notification of major interests in shares
1. Identity of the issuer or the underlying FINSBURY WORLDWIDE
issuer of existing shares to which voting PHARMACEUTICAL TRUST PLC
rights are attached:
2. Reason for the notification (please tick the appropriate box or
boxes):
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issued to which voting rights
are attached
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the ASSET VALUE INVESTORS LIMITED
notification obligation: (ON BEHALF OF CLIENTS)
4. Full name of shareholder(s) (if different SEE SECTION 9
from 3.):
5. Date of the transaction and date on which 2 FEBRUARY 2007
the threshold is crossed or reached:
6. Date on which issuer notified: 8 FEBRUARY 2007
7. Threshold(s) that is/are crossed or reached: ABOVE 3%
8. Notified details: N/A
A: Voting rights attached to shares
Class/type Situation Resulting situation after the triggering
of shares previous to the transaction
Triggering
if possible transaction
using the
ISIN CODE
Number of Number Number of Number of voting % of voting
Shares of shares rights ix rights
Voting
Rights Direct Direct x Indirect Direct Indirect
viii xi
25p 2,744,500 3,744,500 3,744,500 N/A 6.56% N/A
ORDINARY
B: Financial Instruments
Resulting situation after the triggering transaction xii
Type of Expiration Exercise/ Number of voting % of voting
financial date xiii Conversion Period/ rights that may be rights
instrument Date xiv acquired if the
instrument is
exercised/
converted.
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights % of voting rights
3,744,500 6.56%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable xv:
BONY NOMINEES - 570,911 SHARES - AVI VALUE FUND LLC
CHASE NOMINEES - 1,966,440 SHARES - BRITISH EMPIRE SECURITIES
STATE STREET NOMINEES - 140,028 SHARES - CARNEGIE CORPORATION
BONY NOMINEES - 195,922 SHARES - CF AVI GLOBAL FUND
MELLON NOMINEES - 149,095 SHARES - COLUMBIA UNIVERSITY (NON VOTING)
PICTET NOMINEES - 96,698 SHARES - LORD NORTH STREET
CHASE NOMINEES - 150,562 SHARES - ROCKEFELLER UNIVERSITY
NORTRUST NOMINEES - 474,844 SHARES - YALE UNIVERSITY
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will N/A
cease to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: NOTIFICATION USING SHARES IN ISSUE FIGURE OF
57, 056,881 AS AT 1 FEBRUARY 2007
14. Contact name: Company Secretarial Department
15. Contact telephone number: 020 7426 6219
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.